Amgen (AMGN) PT Raised to $193 at Cowen Post Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Piper Jaffray Raises Price Target on Amgen (AMGN) to $200 Following 2Q EPS Beat
July 31, 2015 10:47 AM EDTPiper Jaffray reiterated an Overweight rating on Amgen (NASDAQ: AMGN), and raised the price target to $200.00 (from $192.00), following 2Q earnings results. Total revenue of $5.37B was ahead of consensus by $64M. EPS of $2.57 beat estimates by $0.16 aided by lower than expected R&D.... More
Amgen (AMGN) Tops Q2 EPS by 14c, Raises FY Guidance
July 30, 2015 4:05 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $2.57, $0.14 better than the analyst estimate of $2.43. Revenue for the quarter came in at $5.37 billion versus the consensus estimate of $5.32 billion.
Second Quarter 2015 Product Sales Performance
Total product sales increased 6 percent for the second quarter of 2015 versus the second quarter of 2014. The increase was driven primarily by ENBREL, Prolia, Sensipar, Kyprolis and XGEVA. Growth for the... More
